Advanced Clinical: Advanced Clinical chosen as CRO for Paradigm's Phase III osteoarthritis trial
Paradigm Biopharmaceuticals has selected Advanced Clinical as the CRO to support its Phase III trial, PARA_OA_012, focused on treating OA. The post Advanced Clinical chosen as CRO for Paradigm's Phase III osteoarthritis trial appeared first on Clinical Trials Arena.
Read full article »
Advanced Clinical Services provides biometrics, clinical monitoring and project management solutions for pharmaceutical and biopharmaceutical sectors.
Read more